In this issue:
- HCV-specific CD4+ T-cells susceptible to HIV-1 contribute to viral persistence during ART
- HIV care outcomes for transgender women vs. cisgender people
- Obesity, diabetes, hypertension and major adverse CV events after switching to INSTI
- Incident diabetes after switching to INSTI for HIV
- STI-driven antibiotics, and macrolide/tetracycline resistance for nasal S. aureus
- Anal HPV burden and abnormal cytology in MSM using PrEP vs. MSM with HIV
- MASLD linked to antiretroviral exposure in HIV cohort
- HIV cascade, key indicators and other epidemiological metrics in Australia
- HBV reactivation in people with HIV and isolated anti-HBc receiving tenofovir-sparing dual ART
- Pet ownership: durable viral suppression, but HIV care access challenges
Please login below to download this issue (PDF)